Mission for Movement, is working to bring awareness to the disease and will host a free Parkinson's screening event on Friday ...

A pesticide commonly used in America’s food supply has been linked to Parkinson’s disease, new research suggests.

Oryon Cell Therapies’ lead cell therapy is an autologous treatment designed to replace dopaminergic neurons in patients with Parkinson’s disease. Phase 1b/2a data showed that the asset can improve ...

Study conducted in collaboration with the Neuroregeneration Institute at McLean HospitalAutologous neuronal cell therapy for Parkinson’s disease shows sustained motor improvements and neuroimaging ...

At the 20th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD) in Copenhagen, Eli Lilly and Company presented new data evaluating the ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Fatigue, cognitive changes and sleep disturbances were as important to patients with early Parkinson’s disease as symptoms ...

Researchers argue that neurologists should integrate spiritual assessment into care to help patients with Parkinson’s and dementia find meaning.

Objectives Parkinson’s disease (PD) is a complex, progressive neurological disorder with motor and non-motor symptoms. Among the non-motor symptoms, constipation severely affects the patients’ quality ...

Can our homes help detect brain changes? New research shows how digital sensing reveals subtle shifts in movement and cognition in everyday life, and can track disease progression.

Kneu Health, a precision neurology platform for Parkinson's and dementia, today announced it has graduated from the Global Incubator program at Texas Medical Center Innovation (TMCi). Delivered in ...

CLEVELAND, Ohio — The Cleveland Clinic’s under-construction $1 billion Neurological Institute and its recently announced upcoming Level 1 trauma center are just a few of the building projects in the ...